Availability of HIV-related health services in adolescent substance abuse treatment programs

Abstract

Given that alcohol and drug abuse heightens the risk of adolescents acquiring HIV, substance abuse treatment programs for youths may represent an important site of HIV prevention. In this research, we explored the adoption of three HIV-related health services: risk assessment during intake, HIV prevention programing, and HIV testing. Data were collection through telephone interviews with 149 managers of adolescent-only substance abuse treatment programs in the USA. About half of these programs had adopted HIV risk assessment and HIV prevention. On-site HIV testing was less widely adopted, with only one in four programs offering this service. At the bivariate level, the availability of on-site primary medical care and the availability of an overnight level of care were positively associated with these three types of services. The association for the measure of an overnight level of care was no longer significant once medical services were controlled. However, in a separate analysis, it was found that programs offering an overnight level of care were much more likely to offer on-site medical care than outpatient-only facilities. There was also evidence that publicly funded treatment programs were more likely to offer HIV prevention and on-site HIV testing, after controlling for other organizational characteristics. Much more research about the adoption of HIV-related services in adolescent substance abuse treatment is needed, particularly to offer greater insight into why certain types of organizations are more likely to adopt these health services.

Keywords:

• substance abuse treatment
• HIV prevention
• HIV testing
• health services research

Acknowledgements

This research was supported by a grant from the Robert Wood Johnson Foundation's Substance Abuse Policy Research Program (No. 053130). The original samples of programs in the National Treatment Center Study were constructed through support from the National Institute on Drug Abuse (R01DA13110 and R01DA14482). The authors gratefully acknowledge Dr. Paul M. Roman for access to these samples. Dr. Carrie Oser's work on this research was also supported by the National Institute on Drug Abuse (K01DA021309).